Navigation Links
West Wireless Health Institute Applauds House Passage of Bill to Streamline FDA Medical Device Approval Process, Expedite Mobile Medical App Guidance
Date:6/20/2012

SAN DIEGO, June 20, 2012 /PRNewswire-USNewswire/ -- The West Wireless Health Institute (WWHI) today applauded the U.S. House of Representatives for passing legislation that ensures patients will have timely access to safe medical devices at reduced costs.

(Logo: http://photos.prnewswire.com/prnh/20120606/DC19778LOGO )

Currently, the FDA's de novo process forces manufacturers of low-risk medical devices to submit a 510(k) application, complete a standard review, and obtain a "Not Substantially Equivalent" finding before they can submit a request to have the device reclassified from Class III into Class I or II.  This results in rare use of the de novo process and unnecessarily delays the ability of industry to get innovative technology into the hands of patients at lower costs.  WWHI worked with California Representatives Brian Bilbray and Lois Capps to improve this process as part of the "Food and Drug Safety and Innovation Act" (H.R. 5651).

"We commend Representatives Bilbray and Capps for their leadership in ensuring that new, innovative, low- to moderate-risk devices will reach patients more quickly by streamlining the FDA approval process," said Dr. Joseph Smith, Chief Medical and Science Officer of the West Wireless Health Institute. "Common sense policies create clear regulatory pathways and expedite the entry of new technologies into the health care system to lower the cost of care.  Many wireless devices lack predicates so the de novo reform is particularly helpful for them, and more importantly, it benefits patients with timely access to new medical devices."

Last fall, the WWHI President testified before the House Energy and Commerce Committee on the importance of streamlining FDA's de novo approval process. Those recommendations were later incorporated into the legislation offered by Reps. Bilbray and Capps and passed as part of the FDA bill today.  The legislation also clears the way for the FDA to issue mobile medical app guidance, rather than place a moratorium on FDA guidance exempting most mobile apps, smartphones, and distributors from excessive testing requirements.

"Mobile apps have revolutionized countless industries by putting the power of complex technologies into consumers' hands, yet regulators haven't issued clear guidance on the medical use of apps," said Smith.  "Providing expedited guidance and a clear pathway for mobile medical apps will get low-cost solutions like these into the hands of patients without needless delay."

ABOUT THE WEST WIRELESS HEALTH INSTITUTE

The West Wireless Health Institute (www.westwirelesshealth.org) is the only medical research organization in the world focused on lowering health care costs through technology and innovation. The Institute was founded in 2009 by the Gary and Mary West Foundation, and is based in San Diego, California, the global center for health care innovation.


'/>"/>
SOURCE West Wireless Health Institute
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. First successful human results achieved: Implantable wireless microchip drug delivery device
2. Successful human tests for first wirelessly controlled drug-delivery chip
3. Low-cost paper-based wireless sensor could help detect explosive devices
4. Cambridge Healthtech Associates™ Co-Sponsors BIO Debrief Networking Reception with Xconomy
5. Healthpoint Biotherapeutics To Create State-of-the-Art Cell Sciences Manufacturing Facility
6. Economic Alliance of Greater Baltimore Inks Business Partnership with BioHealth Innovation to Bring Health and Life Sciences Research to Market
7. BioPharm Systems Launches Services to Help Phase I Clinics Implement Oracle Health Sciences LabPas
8. Mayor Bloomberg: Health Crusader or Nanny State Despot?
9. Is Brazil the Next Big Thing in Healthcare?
10. Luminex Corporation to Present at Jefferies 2012 Global Healthcare Conference
11. Auxilium Pharmaceuticals, Inc. to Present at the Jefferies 2012 Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... Linda, Ca (PRWEB) , ... April 18, 2017 , ... ... new technological advances. This webinar, which is part of the Protein and Cell ... Flow Cytometer and outline where this technology fits in current and future applications. ...
(Date:4/19/2017)... ... April 18, 2017 , ... Optofluidics today announced ... comes after the company changed focus to making analytical tools for biopharmaceutical quality ... new technology,” says CEO Robert Hart. Founders Bernardo Cordovez, Robert Hart and David ...
(Date:4/19/2017)... MA (PRWEB) , ... April 19, 2017 , ... ... a $1.5M Series A-1 financing round. This event adds to several other early ... of its’ Executive and Scientific Teams. , ThermaGenix will use proceeds ...
(Date:4/19/2017)... ... April 19, 2017 , ... As ... educational webinars accessible to novices as well as experienced users, attendees will gain ... performed coagulation screening tests. , Hemostasis testing quality is determined by preanalytical ...
Breaking Biology Technology:
(Date:4/13/2017)... According to a new market research report "Consumer IAM Market by Solution ... Authentication Type, Deployment Mode, Vertical, and Region - Global Forecast to 2022", ... 14.30 Billion in 2017 to USD 31.75 Billion by 2022, at a ... ... MarketsandMarkets Logo ...
(Date:4/11/2017)... 11, 2017 NXT-ID, Inc. (NASDAQ:   ... announces the appointment of independent Directors Mr. Robin D. ... Board of Directors, furthering the company,s corporate governance and expertise. ... Gino Pereira , ... forward to their guidance and benefiting from their considerable expertise ...
(Date:4/5/2017)... KEY FINDINGS The global market ... CAGR of 25.76% during the forecast period of 2017-2025. ... for the growth of the stem cell market. ... MARKET INSIGHTS The global stem cell market is segmented ... The stem cell market of the product is segmented ...
Breaking Biology News(10 mins):